BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2185043)

  • 1. Follicle cysts after menstrual versus midluteal administration of gonadotropin-releasing hormone analog in in vitro fertilization.
    Herman A; Ron-El R; Golan A; Nahum H; Soffer Y; Caspi E
    Fertil Steril; 1990 May; 53(5):854-8. PubMed ID: 2185043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of baseline cysts at the time of administration of gonadotropin-releasing hormone analog for in vitro fertilization.
    Zeyneloglu HB; Isik AZ; Kara S; Senöz S; Ozcan U; Gökmen O
    Int J Fertil Womens Med; 1998; 43(6):300-5. PubMed ID: 9920539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone.
    Guo YH; Lu N; Zhang Y; Su YC; Wang Y; Zhang YL; Sun YP
    Contemp Clin Trials; 2012 Nov; 33(6):1206-10. PubMed ID: 22820320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    J Assist Reprod Genet; 1998 Nov; 15(10):599-604. PubMed ID: 9866068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicle cyst formation after administration of different gonadotrophin-releasing hormone analogues for assisted reproduction.
    Tarlatzis BC; Bili H; Bontis J; Lagos S; Vatev I; Mantalenakis S
    Hum Reprod; 1994 Nov; 9(11):1983-6. PubMed ID: 7868660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome.
    Keltz MD; Jones EE; Duleba AJ; Polcz T; Kennedy K; Olive DL
    Fertil Steril; 1995 Sep; 64(3):568-72. PubMed ID: 7641912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavior of follicle cysts formed after long-acting gonadotropin-releasing hormone analog administration in patients with polycystic ovarian syndrome.
    Ellenbogen A; Abu-Asbah I; Libal Y; Jaschevatzky O; Anderman S; Ballas S
    Gynecol Endocrinol; 1997 Apr; 11(2):101-4. PubMed ID: 9174850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian hyperstimulation due to long-term pulsatile intravenous GnRH treatment.
    Geisthövel F; Peters F; Breckwoldt M
    Arch Gynecol; 1985; 236(4):255-9. PubMed ID: 3927855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization.
    Segal S; Casper RF
    Fertil Steril; 1992 Jun; 57(6):1254-8. PubMed ID: 1601147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.
    Qublan HS; Amarin Z; Tahat YA; Smadi AZ; Kilani M
    Hum Reprod; 2006 Mar; 21(3):640-4. PubMed ID: 16253965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
    Gelety TJ; Pearlstone AC; Surrey ES
    Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone agonist.
    Ron-El R; Herman A; Golan A; van der Ven H; Caspi E; Diedrich K
    Fertil Steril; 1990 Aug; 54(2):233-7. PubMed ID: 2143145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization.
    San Roman GA; Surrey ES; Judd HL; Kerin JF
    Fertil Steril; 1992 Oct; 58(4):744-9. PubMed ID: 1426320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyst aspiration or GnRH antagonist administration for ovarian cysts detected at the start of fresh in vitro fertilization cycles.
    Pereira N; Amrane S; Hobeika E; Lekovich JP; Chung PH; Rosenwaks Z
    Gynecol Endocrinol; 2016 Jul; 32(7):562-5. PubMed ID: 26850271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction.
    Fiszbajn GE; Lipowicz RG; Elberger L; Grabia A; Papier SD; Brugo Olmedo SP; Chillik CF
    J Assist Reprod Genet; 2000 May; 17(5):260-3. PubMed ID: 10976412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.